Bio-Business Development Consultancy
Pharmaceutical and biotechnology business development consultancy for market research and marketing, technology valuation, partnering, due diligence, funding and business plan review.
Research institutes, universities, start-up companies, investors and multinationals have all used my consultancy service to help them assess the commercial potential of biotechnology and pharmaceutical derived technologies and products. This often occurs when research throws up a biotechnology or a bio-product that is not part of their core operations and as a consequence, they do not have the in house expertise to assess its true value. In these situations I can help them to make decisions on patenting, to find out-licensing or business partners, or to help develop business plans for a spinout company.
Occasionally an unexpected bioscience application is found for a product by a non-biotech company. In these cases my consultancy focuses on assessing the size of the market for the product, the market growth and how to reach the customers. Understanding the type of biotechnology used by small bio-businesses and obtaining access to large pharmaceutical companies is particularly difficult for non-biotech companies, but with my experience, I can help to bring the technology before a whole range of new customers.
My bio-business development consultancy service includes:-
- Out-licensing of clients’ patents, research leads or biotechnology
- Formation of biotechnology and pharmaceutical spinout companies, development of business plans, and identifying funding sources
- Estimates of market growth for biotechnology and pharmaceutical products
- Assisting with bio-product marketing using technical communications and finding new customers
- Business opportunities and growth into new technical markets
- Due diligence assessment of biotechnology and pharmaceutical business plans for investors
My Experience
My bio-business development consultancy is founded on my broad experience of the functions required to research, develop and manufacture both biologics and chemicals for medicines and agriculture. This breadth was obtained during 30 years of direct technical involvement in biotechnology firms in bioprocessing, high-throughput screening and analytical roles. I know where the scientists and managers are within an organisation, how they get their funding, how to contact them and what they need.
Over the years I have been involved in the technical and business assessment of over 100 research proposals in which I have gained invaluable experience assessing projects for their commercial value as well as technical viability. As a consultant I can pass on this experience to help my clients to understand and to realise the full value of their products and technology.
Setting up my own small business twelve years ago, and assisting in the formation of other start-up companies has helped me to expand my profit-driven business sense with knowledge of costs and timings, access to funding sources and an extensive network of contacts and colleagues. I can help my clients to turn a research concept into a business reality.
Bio-Business Expertise
- Assessing the technical potential of over 100 biological research projects to meet commercial as well as goals
- Key roles in the formation of spinout bioscience and pharmaceutical companies
- Multiple and high level contacts in many European and North American pharmaceutical businesses
- Knowledge of market sizes, growth potential, technical and business drivers of healthcare, pharmaceutical and biotechnology industries
- Intimate knowledge and access to UK contract research organisations of value to biotechnology R&D
- Access to key personnel in emerging businesses through university innovation centre contacts, patent surveillance and business networks
Contact me now to see how my bio-business development consultancy service can add value to your business.
Out licensing of an Anti-fungal
A major US agricultural company, when screening for novel pesticides, had discovered a powerful anti-fungal agent. They were interested in whether it would have any value as a human anti-fungal medicine. Using my network I was able to obtain preliminary data showing a powerful anti-fungal activity against a spectrum of human pathogens. This became part of the data package which was sent to a select list of pharmaceutical companies whom I had identified as being potentially interested in such a lead chemical. The ability to raise such interest in an early stage lead was based on my ability to identify and target those companies that had active anti-fungal discovery programs and then target the discovery directors as well as the corporate in-licensing groups. The compound was successfully out-licensed after an extremely competitive bidding stage.
Market for Vacuum Dryer
A small UK manufacturer of drying equipment wanted me to tell them how their products were being used by the pharmaceutical industry. After giving the MD and senior staff a briefing about the role of their equipment in drug discovery programs, I was able to provide estimates of the market size and potential for future growth. This helped them to decide the extent to which they would expand their manufacturing facilities.
Market for Improved Biotherapeutic Proteins
A UK university spin-out company had a novel technology for a polymer that would improve the bioavailability of therapeutic proteins. They commissioned me to survey the existing market to see if there was any potential for them to use their technology to produce non-proprietary therapeutic proteins but with improved pharmacology. As a result, I was able to point to a small but significant market opportunity for their product. I was also able to identify potential partners and contract research organisations (CROs) that could help them progress down this avenue.
A major US agricultural company, when screening for novel pesticides, had discovered a powerful anti-fungal agent. They were interested in whether it would have any value as a human anti-fungal medicine.... more>
A small UK manufacturer of drying equipment wanted me to tell them how their products were being used by the pharmaceutical industry.... more>
A UK university spin-out company had a novel technology for a polymer that would improve the bioavailability of therapeutic proteins. They commissioned me to survey the existing market to see if there was any potential for their technology....more>